Health Condition 1: - Health Condition 2: I248- Other forms of acute ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Sahajanand Laser Technology Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Males and Females more than 18 years of age. 2. Subjects who had signed the Hospital Consent Form. 3. The subjects who have been treated with PCI and implanted with Neohexa Drug-Eluting Stent as a part of their treatment of Coronary Artery Disease without any further indication for emergent coronary artery bypass graft surgery 4. Patients who have completed a minimum of 24 months after device implantation (device implanted between 01-01-2017 to 31-12-2019)
Exclusion criteria
Exclusion criteria: 1. Subjects who are treated with stents other than Neohexa stent in the same vessel. 2. Subjects implanted with Neohexa stent after 31-12-2019
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative MACE at time of follow-up. MACE is defined as a composite of cardiac death, myocardial infarction and target lesion revascularization. Sustained relief in angina/ angina equivalent symptoms at the time of follow-up without need for target lesion revascularizationTimepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Individual components of MACE all-cause mortality, target vessel revascularization, and stent thrombosis. stent thrombosis shall be further divided as definite, probable, and possible ST as defined by the academic research consortiumTimepoint: 2 years | — |
Countries
India
Contacts
Public ContactPreeti Vani
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Outcome results
None listed